Cargando…

The Emerging Role of Pathogenesis of IgA Nephropathy

IgA nephropathy is an autoimmune disease induced by fthe ormation of galactose-deficient IgA1 and anti-glycans autoantibody. A multi-hit hypothesis was promoted to explain full expression of IgA nephropathy. The deposition of immune complex resulted in activation of the complement, increasing oxidat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Meng-Yu, Chen, Chien-Sheng, Yiang, Giou-Teng, Cheng, Pei-Wen, Chen, Yu-Long, Chiu, Hsiao-Chen, Liu, Kuan-Hung, Lee, Wen-Chin, Li, Chia-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112037/ https://www.ncbi.nlm.nih.gov/pubmed/30127305 http://dx.doi.org/10.3390/jcm7080225

Ejemplares similares

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
por: Chang, Sheng, et al.
Publicado: (2020)

New insights into the pathogenesis of IgA nephropathy
por: Yeo, See Cheng, et al.
Publicado: (2017)

Advanced Evolution of Pathogenesis Concepts in Cardiomyopathies
por: Li, Chia-Jung, et al.
Publicado: (2019)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
por: Tanaka, Mototsugu, et al.
Publicado: (2011)

New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome
por: Yang, Chin-Yao, et al.
Publicado: (2018)

IgA nephropathy pathogenesis and therapy: Review & updates
por: Habas, Elmukhtar, et al.
Publicado: (2022)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021)

The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review
por: Farooq, Hareem, et al.
Publicado: (2021)

New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
por: Magistroni, Riccardo, et al.
Publicado: (2015)

Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
por: Suzuki, Hitoshi
Publicado: (2018)

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy
por: Kano, Toshiki, et al.
Publicado: (2022)

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy
por: Scionti, Katrin, et al.
Publicado: (2021)

The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
por: Tsai, Yu-Ling, et al.
Publicado: (2017)

Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy
por: Juan, Yun-Ting, et al.
Publicado: (2022)

MicroRNAs in IgA nephropathy
por: Yao, Xingchen, et al.
Publicado: (2021)

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy
por: Suzuki, Hitoshi, et al.
Publicado: (2022)

IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
por: Du, Yating, et al.
Publicado: (2023)

The role of mononuclear phagocyte system in IgA nephropathy: pathogenesis and prognosis
por: Liu, Yiwen, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis
por: Chiu, Hsiao-Chen, et al.
Publicado: (2019)

Increased Lifetime Risk of ESRD in Familial IgA Nephropathy
por: Shi, Manman, et al.
Publicado: (2020)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Protection of rhein on IgA nephropathy mediated by inhibition of fibronectin expression in rats
por: Sheng-Nan, Peng, et al.
Publicado: (2013)

Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience
por: SU, QingXiao, et al.
Publicado: (2021)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
por: Zachova, Katerina, et al.
Publicado: (2020)

Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy
por: Li, Guanhong, et al.
Publicado: (2019)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_06tp6858lelovo9pih9r3su56b